An improved method for the isolation of free-circulating plasma DNA and cell-free DNA from other body fluids.

An improved method for the isolation of free-circulating plasma DNA and cell-free DNA from other body fluids. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

An improved method for the isolation of free-circulating plasma DNA and cell-free DNA from other body fluids. Abstract Text:

Cell-free DNA is of increasing interest in different fields, such as cancer research, prenatal diagnosis, and the diagnosis of nonmalignant diseases. The quantity of free-circulating DNA in plasma, serum, and other body fluids is usually low and its isolation is still a challenge. Here we evaluate the application of the new commercially available NucleoSpin Plasma XS Kit for the isolation of cell-free DNA from plasma, serum, and cell-free bronchial lavage samples. The NucleoSpin columns proved superior to the QIAamp system in terms of DNA yield, purity, and retrieval of small DNA fragments. The procedure is fast and easy to standardize and might be valuable for laboratories working in the field of CNAPS.

An improved method for the isolation of free-circulating plasma DNA and cell-free DNA from other body fluids. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

An improved method for the isolation of free-circulating plasma DNA and cell-free DNA from other body fluids. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Annals of the New York Academy of Sciences

VOLUME: 1137

Page Numbers: 135-9

Journal Abbreviation: Ann. N. Y. Acad. Sci.

ISSN: 1749-6632

DAY: 7

MONTH: Aug

YEAR: 2008

An improved method for the isolation of free-circulating plasma DNA and cell-free DNA from other body fluids. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7506858

An improved method for the isolation of free-circulating plasma DNA and cell-free DNA from other body fluids. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: An improved method for the isolation of free-circulating plasma DNA and cell-free DNA from other body fluids. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for An improved method for the isolation of free-circulating plasma DNA and cell-free DNA from other body fluids.

AFFILIATION: MACHEREY-NAGEL GmbH & Co. KG, Düren, Germany.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Ann N Y Acad Sci

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

An improved method for the isolation of free-circulating plasma DNA and cell-free DNA from other body fluids Related Publications

• Alcohol and/or benzodiazepine use in injured road users.
• Alcohol and/or benzodiazepine use: different accidents--different impacts?
• An improved method for the isolation of free-circulating plasma DNA and cell-free DNA from other body fluids.
• Brain activation patterns during a selective attention test-a functional MRI study in healthy volunteers and patients with schizophrenia.
• Clock drawing, clock reading, clock setting, and judgment of clock faces in elderly people with dementia and depression.
• Compliance with antipsychotic treatment.
• Conflicting views on conflicts of interest in medicine.
• Integrity of cell-free plasma DNA in patients with lung cancer and nonmalignant lung disease.
• Interpretation of the Pandy test.
• Language lateralization in unmedicated patients during an acute episode of schizophrenia: a functional MRI study.
• Longitudinal volumetric MRI study in first- and multiple-episode male schizophrenia patients.
• Neopterin production in acute schizophrenic patients: an indicator of alterations of cell-mediated immunity.
• New drugs for the treatment of schizophrenic patients.
• No evidence for an association between serum cholesterol and the course of depression and suicidality.
• Not Available
• Not Available
• Perspectives on treatment needs in schizophrenia.
• Schizophrenia today: do we know any more and can we treat it better than a decade ago?
• Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia.
• [Beta blockers in psychiatric diseases. Indications and problems]
• [Blood diseases.]
• [Blood diseases.]
• [Blood diseases.]
• [Cytostatic therapy.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Preleukemic states.]
• [The problems of older people]